Frank Q. is the Scientific Director of Large Molecules/Biologics Product Development at Johnson & Johnson, where they focus on CMC development, tech transfer, and cGMP manufacturing of antibody and antibody drug conjugate products. They previously served as Associate Director at Bristol-Myers Squibb from 2002 to 2014 and as Head of Biologics Product Development at MacroGenics, Inc. from 2014 to 2015. Frank is currently pursuing a Ph.D. in Chemistry at Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices